Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GCA Savvian was a prominent global investment bank that provided M&A, capital markets, and strategic advisory services, with a specialized focus on the healthcare, technology, and digital media industries. Formed in 2006 through the merger of Japan's GCA and the US-based Savvian, the firm established itself as a leader in cross-border transactions involving life sciences and medical technology companies. In 2016, the company expanded its European footprint by merging with Altium to form GCA Altium. The firm was eventually acquired by Houlihan Lokey in 2021 for approximately $600 million. This acquisition integrated GCA’s extensive healthcare advisory expertise into Houlihan Lokey’s global platform, creating one of the largest technology and healthcare advisory teams in the world.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GCA Savvian.